Oncotarget | Unlocking the potential of molecular-driven stratification of osteosarcoma
2023-03-20
(Press-News.org) BUFFALO, NY- March 20, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, “Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis.”
Over the last 40 years, the complex genetic landscape, the heterogeneity of the microenvironment and the cell plasticity of Osteosarcoma (OSA) tumors have delayed the therapeutic and prognostic stratification of patients and the introduction of new efficient treatments.
As a direct consequence, the vast majority of trials still don’t benefit from a selection of OSA patient-based on molecular evidence before drug administration. This lack of stratification leads to difficult interpretation of outcome, especially with targeted agents such as multikinase inhibitors or anti-osteoclastic drugs.
“Meanwhile, fortunately, the accumulation of numerous sparse but converging observations from many research and clinical teams have progressively drawn a portrait of the resistant osteosarcoma that’s paved the way to new translational discoveries.”
In their new editorial, researchers Gaël Moquin-Beaudry, Maria Eugenia Marques da Costa, Nathalie Gaspar, and Antonin Marchais from Université Paris-Saclay discussed their recent study using unsupervised machine learning algorithms to classify OSA at diagnosis based on gene expression modules functionally enriched for immune microenvironment and tumor phenotypic traits.
“Recently, several important studies have described OSA molecularly at an unprecedent[ed] level of detail taking advantage of multiomics approaches and artificial intelligence [1–3].”
Read the full editorial: DOI: https://doi.org/10.18632/oncotarget.28364
Correspondence to: Antonin Marchais
Email: ANTONIN.MARCHAIS@gustaveroussy.fr
Keywords: multiomics, osteosarcoma, bone sarcoma, stratification
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-03-20
Managers spend much of their time managing conflict and struggle to know how to respond when a ‘he-said-she-said’ workplace dispute occurs. However, a new study shows how employees’ intuitive moral values might give rise to feelings of sympathy toward alleged perpetrators and anger toward their accusing victims. The research, published in this month’s edition of Organization Science, also offers novel insights into what enables perpetrators to go unpunished and why their victims experience backlash for coming forward. ...
2023-03-20
University of Wyoming researchers’ study of how microscopic creatures called tardigrades survive extreme conditions has led to a major breakthrough that could eventually make life-saving treatments available to people where refrigeration isn’t possible.
Thomas Boothby, an assistant professor of molecular biology, and colleagues have shown that natural and engineered versions of tardigrade proteins can be used to stabilize an important pharmaceutical used to treat people with hemophilia ...
2023-03-20
In a new study, North Carolina State University researchers found they could separate blended cotton and polyester fabric using enzymes – nature’s tools for speeding chemical reactions. Ultimately, they hope their findings will lead to a more efficient way to recycle the fabric’s component materials, thereby reducing textile waste.
However, they also found the process need more steps if the blended fabric was dyed or treated with chemicals that increase wrinkle resistance.
“We can separate all of the cotton out of a cotton-polyester blend, meaning now we have clean polyester ...
2023-03-20
New University of Limerick, Ireland research has revealed that most treatments being offered to teenagers with persistent back pain are ‘outdated’ and ignore ‘big picture’ issues.
The study, carried out by researchers at University of Limerick along with colleagues in the UK and Australia, has shown that new approaches to tackling back pain are not being tested among teenagers.
The research, published in the European Journal of Pain, reveals that there is a lack of treatments addressing ...
2023-03-20
AAV is a multi-organ disease, which can be complex and may vary from person to person. Types of AAV include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). This variety can make management challenging. Comorbidities, an individual’s history, toxicities, medication availability and cost, and patient preferences should all be considered in the process of informed decision making.
EULAR first wrote recommendations ...
2023-03-20
Amsterdam, March 20, 2023 – In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients treated outside of clinical trials confirm that long-term suppressive therapy with BLV monotherapy has the potential to reduce viral replication and improve liver tests of these difficult-to-treat patients for the first time in 45 years, report investigators in the Journal of Hepatology and its companion journal JHEP Reports.
Two of the studies, led by Pietro Lampertico, MD, PhD, Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ ...
2023-03-20
ALBUQUERQUE, N.M. — In a major breakthrough in the fields of nanophotonics and ultrafast optics, a Sandia National Laboratories research team has demonstrated the ability to dynamically steer light pulses from conventional, so-called incoherent light sources.
This ability to control light using a semiconductor device could allow low-power, relatively inexpensive sources like LEDs or flashlight bulbs to replace more powerful laser beams in new technologies such as holograms, remote sensing, self-driving cars and high-speed ...
2023-03-20
How fresh are your data? For drones searching a disaster zone or robots inspecting a building, working with the freshest data is key to locating a survivor or reporting a potential hazard. But when multiple robots simultaneously relay time-sensitive information over a wireless network, a traffic jam of data can ensue. Any information that gets through is too stale to consider as a useful, real-time report.
Now, MIT engineers may have a solution. They’ve developed a method to tailor any wireless network to handle a high load of time-sensitive data coming from multiple sources. Their new approach, ...
2023-03-20
The human body is made up of thousands of tiny lymphatic vessels that ferry white blood cells and proteins around the body, like a superhighway of the immune system. It’s remarkably efficient, but if damaged from injury or cancer treatment, the whole system starts to fail. The resulting fluid retention and swelling, called lymphedema, isn’t just uncomfortable — it’s also irreversible.
When lymphatic vessels fail, typically their ability to pump out the fluid is compromised. Georgia Institute of Technology researchers have developed a new treatment using nanoparticles that can repair lymphatic vessel pumping. Traditionally, ...
2023-03-20
The Chicago Quantum Exchange (CQE) continued to expand its diverse community of quantum researchers, leaders, and institutions in 2022—launching a quantum research fellowship for undergraduates, welcoming 11 new corporate partners, and extending a regional quantum communication network to a total length of 124 miles.
These are among the successes highlighted in the CQE’s newly published annual report, which chronicles the many contributions of the consortium’s members and partners and offers a window into the region’s ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget | Unlocking the potential of molecular-driven stratification of osteosarcoma
